Ritonavir Terminated Phase 4 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
TerminatedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01602822Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV